Suppr超能文献

Pirh2 E3 泛素连接酶将 DNA 聚合酶 eta 靶向 20S 蛋白酶体降解。

Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.

机构信息

Center for Comparative Oncology, University of California, Davis, California 95616, USA.

出版信息

Mol Cell Biol. 2010 Feb;30(4):1041-8. doi: 10.1128/MCB.01198-09. Epub 2009 Dec 14.

Abstract

DNA polymerase eta (PolH), a Y family translesion polymerase, is required for repairing UV-induced DNA damage, and loss of PolH is responsible for early onset of malignant skin cancers in patients with xeroderma pigmentosum variant (XPV), an autosomal recessive disorder. Here, we show that PolH, a target of the p53 tumor suppressor, is a short-half-life protein. We found that PolH is degraded by proteasome, which is enhanced upon UV irradiation. We also found that PolH interacts with Pirh2 E3 ligase, another target of the p53 tumor suppressor, via the polymerase-associated domain in PolH and the RING finger domain in Pirh2. In addition, we show that overexpression of Pirh2 decreases PolH protein stability, whereas knockdown of Pirh2 increases it. Interestingly, we found that PolH is recruited by Pirh2 and degraded by 20S proteasome in a ubiquitin-independent manner. Finally, we observed that Pirh2 knockdown leads to accumulation of PolH and, subsequently, enhances the survival of UV-irradiated cells. We postulate that UV irradiation promotes cancer formation in part by destabilizing PolH via Pirh2-mediated 20S proteasomal degradation.

摘要

DNA 聚合酶 eta(PolH)是一种 Y 家族的跨损伤聚合酶,对于修复 UV 诱导的 DNA 损伤至关重要。失活 PolH 会导致色素性干皮病变异型(XPV)患者的恶性皮肤癌的早发性发生,XPV 是一种常染色体隐性遗传疾病。在这里,我们发现 PolH 是 p53 肿瘤抑制因子的靶标,是一种半衰期短的蛋白质。我们发现 PolH 可被蛋白酶体降解,而蛋白酶体在 UV 照射下会增强。我们还发现 PolH 通过 PolH 的聚合酶相关结构域和 Pirh2 的 RING 指结构域与另一个 p53 肿瘤抑制因子的靶标 Pirh2 E3 连接酶相互作用。此外,我们表明过表达 Pirh2 会降低 PolH 蛋白的稳定性,而敲低 Pirh2 则会增加其稳定性。有趣的是,我们发现 PolH 被 Pirh2 募集并以非泛素依赖的方式通过 20S 蛋白酶体降解。最后,我们观察到 Pirh2 敲低会导致 PolH 积累,随后增强了 UV 照射细胞的存活。我们推测,UV 照射通过 Pirh2 介导的 20S 蛋白酶体降解破坏 PolH,从而促进癌症的形成。

相似文献

1
Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.
Mol Cell Biol. 2010 Feb;30(4):1041-8. doi: 10.1128/MCB.01198-09. Epub 2009 Dec 14.
2
Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis.
Mol Cell Biol. 2011 Oct;31(19):3997-4006. doi: 10.1128/MCB.05808-11. Epub 2011 Jul 26.
3
DNA polymerase eta is targeted by Mdm2 for polyubiquitination and proteasomal degradation in response to ultraviolet irradiation.
DNA Repair (Amst). 2012 Feb 1;11(2):177-84. doi: 10.1016/j.dnarep.2011.10.017. Epub 2011 Nov 6.
6
The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
J Biol Chem. 2011 Oct 14;286(41):35388-35395. doi: 10.1074/jbc.M111.261537. Epub 2011 Aug 18.
7
Aberrant C-terminal domain of polymerase η targets the functional enzyme to the proteosomal degradation pathway.
DNA Repair (Amst). 2015 May;29:154-65. doi: 10.1016/j.dnarep.2015.02.017. Epub 2015 Feb 26.
8
PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
Biochem Biophys Res Commun. 2007 Dec 14;364(2):344-50. doi: 10.1016/j.bbrc.2007.10.003. Epub 2007 Oct 11.
10
Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63.
J Invest Dermatol. 2013 May;133(5):1178-87. doi: 10.1038/jid.2012.466. Epub 2012 Dec 13.

引用本文的文献

2
E3 ubiquitin ligase RNF2 protects polymerase ι from destabilization.
Biochim Biophys Acta Mol Cell Res. 2024 Jun;1871(5):119743. doi: 10.1016/j.bbamcr.2024.119743. Epub 2024 May 3.
3
Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment.
Cancer Res. 2023 May 15;83(10):1573-1580. doi: 10.1158/0008-5472.CAN-22-3631.
4
Nontraditional Roles of DNA Polymerase Eta Support Genome Duplication and Stability.
Genes (Basel). 2023 Jan 9;14(1):175. doi: 10.3390/genes14010175.
6
Revisiting the Function of p21 in DNA Repair: The Influence of Protein Interactions and Stability.
Int J Mol Sci. 2022 Jun 24;23(13):7058. doi: 10.3390/ijms23137058.
7
The Role of E3 Ligase Pirh2 in Disease.
Cells. 2022 Apr 30;11(9):1515. doi: 10.3390/cells11091515.
8
DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target.
Front Oncol. 2022 Feb 7;11:822500. doi: 10.3389/fonc.2021.822500. eCollection 2021.
9
The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.
Cell Death Dis. 2021 Jun 5;12(6):581. doi: 10.1038/s41419-021-03871-w.
10
Genome-wide signatures of mammalian skin covering evolution.
Sci China Life Sci. 2021 Oct;64(10):1765-1780. doi: 10.1007/s11427-020-1841-5. Epub 2021 Jan 19.

本文引用的文献

1
Modes of p53 regulation.
Cell. 2009 May 15;137(4):609-22. doi: 10.1016/j.cell.2009.04.050.
2
Blinded by the Light: The Growing Complexity of p53.
Cell. 2009 May 1;137(3):413-31. doi: 10.1016/j.cell.2009.04.037.
3
Y-family DNA polymerases in mammalian cells.
Cell Mol Life Sci. 2009 Jul;66(14):2363-81. doi: 10.1007/s00018-009-0024-4. Epub 2009 Apr 15.
4
Molecular mechanisms of proteasome assembly.
Nat Rev Mol Cell Biol. 2009 Feb;10(2):104-15. doi: 10.1038/nrm2630.
5
Regulated proteolysis of DNA polymerase eta during the DNA-damage response in C. elegans.
Mol Cell. 2008 Dec 26;32(6):757-66. doi: 10.1016/j.molcel.2008.11.016.
6
Molecular basis of Pirh2-mediated p53 ubiquitylation.
Nat Struct Mol Biol. 2008 Dec;15(12):1334-42. doi: 10.1038/nsmb.1521. Epub 2008 Nov 30.
8
Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.
Cancer Res. 2007 Nov 15;67(22):10789-95. doi: 10.1158/0008-5472.CAN-07-2033.
10
PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
Biochem Biophys Res Commun. 2007 Dec 14;364(2):344-50. doi: 10.1016/j.bbrc.2007.10.003. Epub 2007 Oct 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验